XBI (Biotech) Stock Analysis - AI Report

Biotech (XBI) is a publicly traded the market company. As of May 20, 2026, XBI trades at $131.56 with a market cap of $0 and a P/E ratio of 0.00. XBI moved +3.92% today. Year to date, XBI is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces XBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on XBI?

Rallies AI research for XBI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

XBI Key Metrics

Key financial metrics for XBI
MetricValue
Price$131.56
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume10.38M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest XBI News

XBI Analyst Consensus

XBI analyst coverage data. Average price target: $0.00.

Common questions about XBI

What is the AI research view on XBI?
Rallies AI research for XBI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for XBI?
Rallies AI research for XBI combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is XBI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XBI. It does not provide personalized investment advice.
XBI

Biotech